Financials
值 Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM 销售/总务/管理费用 212 M230 M268 M308 M173 M 979 M 研发 856 M700 M801 M775 M649 M 2.92 B 营业收入 -1.05 B-907 M-260 M-857 M-1.39 B -3.41 B 营业外收入合计 97 M107 M93 M68 M63 M 331 M 利息支出,净利息资本化 ————— — 营业外收入,不包括利息支出 101 M99 M93 M80 M81 M 353 M 非经常性收入/支出 -4 M8 M0-12 M-18 M -22 M 税前收入 -964 M-818 M-187 M-799 M-1.33 B -3.14 B 收益中的权益 -8 M03 M-3 M-2 M -2 M 税收 7 M7 M13 M27 M9 M 56 M 非控股/少数股权 ————— — 税后其他收入/支出 -2 M-34 M-14 M-27 M-6 M -81 M 终止经营前净收入 -971 M-825 M-200 M-826 M-1.34 B -3.19 B 已终止经营 ————— — 净利润 -971 M-825 M-200 M-826 M-1.34 B -3.19 B 稀释调整 ————— — 优先股息 ————— — 普通股股东可获得的稀释净收益 -971 M-825 M-200 M-826 M-1.34 B -3.19 B 每股基本收益(基本 EPS) -2.52-2.13-0.51-2.1-3.4 -8.14 稀释每股收益(稀释 EPS) -2.52-2.13-0.51-2.1-3.4 -8.14 平均流通基本股 386 M388 M390 M389 M395 M — 稀释流通股 386 M388 M390 M389 M395 M — 息税折旧摊销前利润 -1.01 B-851 M-209 M-791 M-1.33 B -3.18 B 息税前利润 -1.05 B-907 M-260 M-857 M-1.39 B -3.41 B 营业成本 90 M119 M207 M452 M955 M 1.73 B 其他销售成本 52 M45 M74 M144 M38 M 301 M 折旧摊销(现金流) 38 M56 M51 M66 M56 M 229 M
新闻
美国股市收低;截至收盘道琼斯工业平均指数下跌1.72%
Moderna在Barclays大会上的发言:战略增长与产品线扩张
美国股市收低;截至收盘道琼斯工业平均指数下跌1.61%
Moderna就专利诉讼与Arbutus和Genevant达成9.5亿美元和解协议
美股收盘:通胀担忧暂缓、油价持稳 科技股带动大盘重拾升势
美国股市上涨;截至收盘道琼斯工业平均指数上涨0.49%
Chardan重申Arbutus Biopharma股票评级,因与Moderna达成协议
Roivant Sciences股价创历史新高,达29.23美元
Moderna股价触及52周高点55.22美元
Moderna股价大涨,和解协议消除重大法律隐患
CrowdStrike、Nvidia和Moderna盘前上涨;Abercrombie & Fitch下跌
图表与思路
MRNA - Long-Term Technical Forecast
Weekly price is located above Ichimoku cloud in the bullish area of the chart for trying to cross the level at 81.36 to above for the strong bullish trend to be continuing. The price is on strong bullish breakout which is confirmed by Stochastic oscillator and Chinkou Span line. If the price breaks the 81.36 level to above on weekly close bar so the strong bullish trend will be continuing. If the price crosses the level at 73.28 to below so the secondary correction will be started. If the price breaks the support level at 43.90 to 36.66 to be crossed on weekly close bar so we may see the primary bearish reversal to be started on this W1 timeframe for example. Alternatively, the price will be on ranging to be near and above Ichimoku cloud waiting for direction. Trading Summary : bullish
0 The MRNA doesn’t have other trading ideas at this time
Browse ready-made trading ideas or select a symbol and create your own
Go to Charts and Trading Ideas